FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380762583> ?p ?o ?g. }

• W4380762583 abstract "Abstract Objectives CD81, a transmembrane protein belonging to the tetraspanin family, has recently attracted attention as a therapeutic target for cancer owing to its important role in human cancer biology; however, there is no previous knowledge regarding CD81 expression in parotid cancer. Therefore, this study aimed to investigate CD81 expression in human parotid cancer and its involvement in cell proliferation. Materials and Methods Tissue samples were collected from 36 patients with parotid cancer, including 10 with salivary duct carcinoma (SDC), 16 with mucoepidermoid carcinoma (MEC), 5 with adenoid cystic carcinoma (ACC), and 5 with carcinoma ex pleomorphic adenoma (Ca ex PA). CD81 expressions in parotid cancer tissues were evaluated using western blotting and immunohistochemistry. Parotid cancer cell lines were established and the effect of suppressing CD81 expression by small interfering RNA (siRNA) and the effect of our anti-CD81 monoclonal antibody on the growth of parotid cancer cells were evaluated. Results The immunohistochemical expressions of CD81 on tumor cell membranes were observed in SDC and MEC tissues but not in ACC and Ca ex PA tissues. Furthermore, inhibition of CD81 expression by siRNA suppresses the growth of parotid cancer cells, and the mouse monoclonal antibody against CD81 inhibited parotid cancer cell growth in a concentration-dependent manner. Conclusions We confirmed the expressions of CD81 in SDC and MEC tissues and showed that its inhibition suppressed the growth of parotid cancer cells. Clinical Relevance These findings provide primary data for the therapeutic targeting of CD81 in parotid cancer." @default.
• W4380762583 created "2023-06-16" @default.
• W4380762583 creator A5000863624 @default.
• W4380762583 creator A5026794011 @default.
• W4380762583 creator A5030491862 @default.
• W4380762583 creator A5038667257 @default.
• W4380762583 creator A5048924536 @default.
• W4380762583 creator A5056265260 @default.
• W4380762583 creator A5064293971 @default.
• W4380762583 creator A5065220909 @default.
• W4380762583 creator A5068306928 @default.
• W4380762583 creator A5070059378 @default.
• W4380762583 creator A5076675171 @default.
• W4380762583 creator A5083525020 @default.
• W4380762583 date "2023-06-15" @default.
• W4380762583 modified "2023-10-03" @default.
• W4380762583 title "Tetraspanin CD81 is expressed in human parotid cancer tissue and mediates cell proliferation" @default.
• W4380762583 cites W1914733225 @default.
• W4380762583 cites W1963560969 @default.
• W4380762583 cites W1967427925 @default.
• W4380762583 cites W1989883027 @default.
• W4380762583 cites W2012129117 @default.
• W4380762583 cites W2014664520 @default.
• W4380762583 cites W2043228552 @default.
• W4380762583 cites W2102052855 @default.
• W4380762583 cites W2528856491 @default.
• W4380762583 cites W2605595591 @default.
• W4380762583 cites W2620567597 @default.
• W4380762583 cites W2803823272 @default.
• W4380762583 cites W2887941182 @default.
• W4380762583 cites W2945581101 @default.
• W4380762583 cites W2971906662 @default.
• W4380762583 cites W2971940967 @default.
• W4380762583 cites W2990809684 @default.
• W4380762583 cites W3000031958 @default.
• W4380762583 cites W3093641368 @default.
• W4380762583 cites W3171232125 @default.
• W4380762583 cites W3176610492 @default.
• W4380762583 cites W4205237319 @default.
• W4380762583 cites W4213126185 @default.
• W4380762583 cites W4285038596 @default.
• W4380762583 cites W4300716327 @default.
• W4380762583 cites W4362670879 @default.
• W4380762583 doi "https://doi.org/10.21203/rs.3.rs-3037775/v1" @default.
• W4380762583 hasPublicationYear "2023" @default.
• W4380762583 type Work @default.
• W4380762583 citedByCount "0" @default.
• W4380762583 crossrefType "posted-content" @default.
• W4380762583 hasAuthorship W4380762583A5000863624 @default.
• W4380762583 hasAuthorship W4380762583A5026794011 @default.
• W4380762583 hasAuthorship W4380762583A5030491862 @default.
• W4380762583 hasAuthorship W4380762583A5038667257 @default.
• W4380762583 hasAuthorship W4380762583A5048924536 @default.
• W4380762583 hasAuthorship W4380762583A5056265260 @default.
• W4380762583 hasAuthorship W4380762583A5064293971 @default.
• W4380762583 hasAuthorship W4380762583A5065220909 @default.
• W4380762583 hasAuthorship W4380762583A5068306928 @default.
• W4380762583 hasAuthorship W4380762583A5070059378 @default.
• W4380762583 hasAuthorship W4380762583A5076675171 @default.
• W4380762583 hasAuthorship W4380762583A5083525020 @default.
• W4380762583 hasBestOaLocation W43807625831 @default.
• W4380762583 hasConcept C121608353 @default.
• W4380762583 hasConcept C126322002 @default.
• W4380762583 hasConcept C142724271 @default.
• W4380762583 hasConcept C1491633281 @default.
• W4380762583 hasConcept C159654299 @default.
• W4380762583 hasConcept C203014093 @default.
• W4380762583 hasConcept C204232928 @default.
• W4380762583 hasConcept C2522874641 @default.
• W4380762583 hasConcept C2776408679 @default.
• W4380762583 hasConcept C2776507628 @default.
• W4380762583 hasConcept C2777208748 @default.
• W4380762583 hasConcept C2777546739 @default.
• W4380762583 hasConcept C2779231225 @default.
• W4380762583 hasConcept C502942594 @default.
• W4380762583 hasConcept C542903549 @default.
• W4380762583 hasConcept C54355233 @default.
• W4380762583 hasConcept C62112901 @default.
• W4380762583 hasConcept C71924100 @default.
• W4380762583 hasConcept C86803240 @default.
• W4380762583 hasConcept C96232424 @default.
• W4380762583 hasConceptScore W4380762583C121608353 @default.
• W4380762583 hasConceptScore W4380762583C126322002 @default.
• W4380762583 hasConceptScore W4380762583C142724271 @default.
• W4380762583 hasConceptScore W4380762583C1491633281 @default.
• W4380762583 hasConceptScore W4380762583C159654299 @default.
• W4380762583 hasConceptScore W4380762583C203014093 @default.
• W4380762583 hasConceptScore W4380762583C204232928 @default.
• W4380762583 hasConceptScore W4380762583C2522874641 @default.
• W4380762583 hasConceptScore W4380762583C2776408679 @default.
• W4380762583 hasConceptScore W4380762583C2776507628 @default.
• W4380762583 hasConceptScore W4380762583C2777208748 @default.
• W4380762583 hasConceptScore W4380762583C2777546739 @default.
• W4380762583 hasConceptScore W4380762583C2779231225 @default.
• W4380762583 hasConceptScore W4380762583C502942594 @default.
• W4380762583 hasConceptScore W4380762583C542903549 @default.
• W4380762583 hasConceptScore W4380762583C54355233 @default.
• W4380762583 hasConceptScore W4380762583C62112901 @default.
• W4380762583 hasConceptScore W4380762583C71924100 @default.
• W4380762583 hasConceptScore W4380762583C86803240 @default.

• next